HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haruaki Kageyama Selected Research

Galanin-Like Peptide

1/2018Regulation of Feeding Behavior and Energy Metabolism by Galanin-like Peptide (GALP): A Novel Strategy to Fight Against Obesity.
1/2017Effect of Intranasal Administration of Galanin-like Peptide (GALP) on Body Weight and Hepatic Lipids Accumulation in Mice with Diet-induced Obesity.
1/2016Anti-obesity effect of intranasal administration of galanin-like peptide (GALP) in obese mice.
7/2013Galanin-like peptide (GALP) facilitates thermogenesis via synthesis of prostaglandin E2 by astrocytes in the periventricular zone of the third ventricle.
5/2008Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins.
3/2005Galanin-like peptide in the brain: effects on feeding, energy metabolism and reproduction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haruaki Kageyama Research Topics

Disease

10Body Weight (Weight, Body)
01/2017 - 05/2003
9AIDS-Related Complex (ARC)
04/2010 - 10/2002
7Obesity
01/2018 - 06/2002
5Insulin Resistance
07/2013 - 06/2002
2Hypertension (High Blood Pressure)
04/2006 - 02/2005
1Weight Loss (Weight Reduction)
01/2017
1Hypertrophy
05/2014
1Malnutrition (Nutritional Deficiencies)
09/2011
1Dwarfism
09/2010
1Insulinoma
08/2010
1Atherosclerosis
08/2009
1Ulcer
07/2009
1Thyroid Neoplasms (Thyroid Cancer)
09/2007
1Hypoadiponectinemia
04/2006
1Narcolepsy
04/2005
1Stroke (Strokes)
02/2005
1Asthma (Bronchial Asthma)
11/2004
1Inflammation (Inflammations)
11/2004
1Hypertriglyceridemia
05/2003
1Weight Gain
05/2003
1Glucose Intolerance
06/2002

Drug/Important Bio-Agent (IBA)

6Galanin-Like PeptideIBA
01/2018 - 03/2005
6LeptinIBA
07/2013 - 05/2003
6Messenger RNA (mRNA)IBA
07/2010 - 10/2002
6OrexinsIBA
12/2009 - 04/2003
4Peptides (Polypeptides)IBA
09/2010 - 05/2003
4Insulin (Novolin)FDA Link
08/2010 - 06/2002
3Glucose (Dextrose)FDA LinkGeneric
07/2013 - 06/2002
3Pro-Opiomelanocortin (Proopiomelanocortin)IBA
07/2010 - 05/2003
3Dihydrotachysterol (AT 10)IBA
07/2010 - 01/2008
3salicylhydroxamic acid (SHAM)IBA
07/2009 - 06/2002
3GhrelinIBA
01/2008 - 09/2003
3Neuropeptide YIBA
03/2005 - 05/2003
2NeuropeptidesIBA
01/2017 - 04/2005
2AdiponectinIBA
05/2014 - 04/2006
2Hormones (Hormone)IBA
08/2009 - 05/2003
2FructoseIBA
04/2006 - 06/2002
1LipidsIBA
01/2017
1Fatty Acids (Saturated Fatty Acids)IBA
02/2016
1Carbachol (Carbastat)FDA Link
05/2014
1AtropineFDA LinkGeneric
05/2014
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
07/2013
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2013
1Melanocortin Receptors (Melanocortin Receptor)IBA
07/2013
1DNA (Deoxyribonucleic Acid)IBA
09/2011
1melanotan-IIIBA
07/2010
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
07/2010
1Ethanol (Ethyl Alcohol)IBA
07/2009
1BIBP 3226IBA
04/2009
1His(5)-Trp(7)-Tyr(8)- LHRHIBA
06/2008
1Angiotensin IIIBA
04/2006
1PD 123319IBA
04/2006
1Amino AcidsFDA Link
03/2005
1GalaninIBA
03/2005
1Nerve Growth Factor (NGF)IBA
02/2005
1Trans-Activators (Trans-Acting Factor)IBA
02/2005
1Proteins (Proteins, Gene)FDA Link
02/2005
1ElementsIBA
02/2005
1Protein Isoforms (Isoforms)IBA
11/2004
1Calcitonin Gene-Related PeptideIBA
11/2004
1Pioglitazone (Actos)FDA Link
05/2003
1Triglycerides (Triacylglycerol)IBA
05/2003
1Sucrose (Saccharose)IBA
05/2003
1Leptin ReceptorsIBA
04/2003
1alpha-MSHIBA
10/2002
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
06/2002

Therapy/Procedure

2Intranasal Administration
01/2017 - 01/2016
1Vagotomy
05/2014
1Intraventricular Infusions
01/2012
1Aftercare (After-Treatment)
06/2008
1Injections
07/2004